Trial Outcomes & Findings for Ketamine Infusion and Hypoventilation (NCT NCT01535976)
NCT ID: NCT01535976
Last Updated: 2014-04-01
Results Overview
Subjects receiving intraoperative ketamine in addition to propofol will demonstrate less hypoventilation during the surgical procedure.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
54 participants
Primary outcome timeframe
8 hours
Results posted on
2014-04-01
Participant Flow
Hospital based recruitment. From August 2011 to June 2012.
Participant milestones
| Measure |
Ketamine
Infusion of ketamine
Ketamine : Ketamine infusion .5mg/kg bolus followed by 1.5 mcg/kg/minute until end of case
|
Placebo
.9 normal saline infusion
Placebo : Placebo Comparator: Placebo
.9 normal saline infusion
|
|---|---|---|
|
Overall Study
STARTED
|
27
|
27
|
|
Overall Study
COMPLETED
|
26
|
26
|
|
Overall Study
NOT COMPLETED
|
1
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Ketamine Infusion and Hypoventilation
Baseline characteristics by cohort
| Measure |
Ketamine
n=27 Participants
Infusion of ketamine
Ketamine : Ketamine infusion .5mg/kg bolus followed by 1.5 mcg/kg/minute until end of case along with propofol 100 mcg/kg/min
|
Placebo
n=27 Participants
normal saline infusion
Placebo : Placebo Comparator: Placebo
normal saline infusion along with propofol 100 mcg/kg/min
|
Total
n=54 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
27 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
54 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Continuous
|
48.4 years
STANDARD_DEVIATION 7.67 • n=5 Participants
|
46.89 years
STANDARD_DEVIATION 7.35 • n=7 Participants
|
47.65 years
STANDARD_DEVIATION 7.55 • n=5 Participants
|
|
Sex: Female, Male
Female
|
27 Participants
n=5 Participants
|
27 Participants
n=7 Participants
|
54 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
27 participants
n=5 Participants
|
27 participants
n=7 Participants
|
54 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 8 hoursPopulation: The median percentage of the sedation time with TCO2 \> 50 mmHg
Subjects receiving intraoperative ketamine in addition to propofol will demonstrate less hypoventilation during the surgical procedure.
Outcome measures
| Measure |
Ketamine
n=26 Participants
Infusion of ketamine
Ketamine : Ketamine infusion .5mg/kg bolus followed by 1.5 mcg/kg/minute until end of case along with propofol 100 mcg/kg/min.
|
Placebo
n=26 Participants
normal saline infusion
Placebo : Placebo Comparator: Placebo
normal saline infusion along with propofol 100 mcg/kg/min
|
|---|---|---|
|
Intraoperative Hypoventilation
|
1.2 % time
95% Confidence Interval 95 • Interval 0.0 to 83.0
|
65 % time
Interval 0.0 to 88.0
|
Adverse Events
Ketamine
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Placebo
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place